What Clinical Strategies Are Applied for Botulinum Toxin Injection in the Oromandibular Region?
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Final published version, 5 MB, PDF document
Merete Bakke, Torben Dalager, Eigild Møller
Botulinum neurotoxin (BoNT) inhibits the release of acetylcholine from cholinergic nerve terminals in muscles or salivary glands. With reduced activation, the muscle activity or secretion decreases. Indications for medical, non‐cosmetic use of BoNT in the orofacial area include among others oromandibular dystonia, painful masseter hypertrophy, Frey's syndrome, and severe drooling. The chapter covers anamnestic characteristics of these conditions as well as clinical, electromyographic (EMG) and laboratory findings, treatment methods with guided injections, and outcome from systematic treatment controls and follow‐up examinations.
|Title of host publication||Botulinum Toxin Therapy Manual for Dystonia and Spasticity|
|Editors||R Rosales, D Dressler|
|Number of pages||17|
|Place of Publication||Rijeka|
|Publication status||Published - 2016|
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available